| Schedule of Segment Reporting Information by Segment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical Research Segment |
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
September 30, |
|
|
September 30, |
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in thousands) |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
Direct program expense |
$ |
9,945 |
|
|
$ |
6,824 |
|
|
$ |
24,149 |
|
|
$ |
22,187 |
|
Indirect program expense |
|
558 |
|
|
|
459 |
|
|
|
1,754 |
|
|
|
1,417 |
|
Workforce salaries and benefits |
|
4,074 |
|
|
|
4,202 |
|
|
|
12,768 |
|
|
|
12,952 |
|
Share-based compensation expense |
|
3,492 |
|
|
|
2,961 |
|
|
|
9,321 |
|
|
|
8,614 |
|
General corporate expenses |
|
1,282 |
|
|
|
1,055 |
|
|
|
3,873 |
|
|
|
3,655 |
|
Interest and other expense |
|
— |
|
|
|
2 |
|
|
|
— |
|
|
|
2 |
|
Segment net loss |
|
19,351 |
|
|
|
15,503 |
|
|
|
51,865 |
|
|
|
48,827 |
|
Reconciliation of loss: |
|
|
|
|
|
|
|
|
|
|
|
Interest income |
|
(1,505 |
) |
|
|
(804 |
) |
|
|
(3,516 |
) |
|
|
(2,813 |
) |
Adjustments and reconciling items |
|
(1,505 |
) |
|
|
(804 |
) |
|
|
(3,516 |
) |
|
|
(2,813 |
) |
Net loss |
$ |
17,846 |
|
|
$ |
14,699 |
|
|
$ |
48,349 |
|
|
$ |
46,014 |
|
|